open access

Ahead of Print
Research paper
Published online: 2021-11-18
Get Citation

The relationship between hsa_circ_0051326 and HLA-G expression in the blood of patients with pre-eclampsia

Li Wang1, Xue Wang2, Xiaoju Chen1, Dongcai Wu1, Hui Cen1, Dongrui Mao1, Yuqiao Mo1, Linmei Zheng1
Affiliations
  1. Department of Obstetrics, Hainan General Hospital, Hainan Affiliated hospital of Hainan medical university, Haikou, China
  2. Department of internal emergency medicine, Hainan General Hospital, Hainan Affiliated hospital of Hainan medical university, Haikou, China

open access

Ahead of Print
ORIGINAL PAPERS Obstetrics
Published online: 2021-11-18

Abstract

Objectives: To investigate the relationship between hsa_circ_0051326 and HLA-G expression in the blood of patients with pre-eclampsia.

Material and methods: Real-time PCR (qRT-PCR) was used to detect the hsa_circ_0051326 expression level. Enzyme-linked immunosorbent assay (ELISA), qRT-PCR, and western blotting were used to detect HLA-G expression in blood in 50 patients with pre-eclampsia and 50 normal pregnant women.

Results: HLA-G protein expression level was decreased significantly in the blood of patients with pre-eclampsia. hsa_circ_0051326 and HLA-G mRNA in blood were decreased significantly in the pre-eclampsia patients compared with normal pregnant women. There was a positive correlation between the expression of serum hsa_circ_0051326 with HLA-G mRNA.

Conclusions: Serum hsa_circ_0051326 was a new diagnostic biomarker for pre-eclampsia with equivalent efficiency of HLA-G. Maternal serum hsa_circ_0051326 level may pre-diagnose potentially pre-eclampsia before delivery.

Abstract

Objectives: To investigate the relationship between hsa_circ_0051326 and HLA-G expression in the blood of patients with pre-eclampsia.

Material and methods: Real-time PCR (qRT-PCR) was used to detect the hsa_circ_0051326 expression level. Enzyme-linked immunosorbent assay (ELISA), qRT-PCR, and western blotting were used to detect HLA-G expression in blood in 50 patients with pre-eclampsia and 50 normal pregnant women.

Results: HLA-G protein expression level was decreased significantly in the blood of patients with pre-eclampsia. hsa_circ_0051326 and HLA-G mRNA in blood were decreased significantly in the pre-eclampsia patients compared with normal pregnant women. There was a positive correlation between the expression of serum hsa_circ_0051326 with HLA-G mRNA.

Conclusions: Serum hsa_circ_0051326 was a new diagnostic biomarker for pre-eclampsia with equivalent efficiency of HLA-G. Maternal serum hsa_circ_0051326 level may pre-diagnose potentially pre-eclampsia before delivery.

Get Citation

Keywords

pre-eclampsia; Human leukocyte antigen-G; hsa_circ_0051326; serum

About this article
Title

The relationship between hsa_circ_0051326 and HLA-G expression in the blood of patients with pre-eclampsia

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2021-11-18

Page views

796

Article views/downloads

439

DOI

10.5603/GP.a2021.0194

Pubmed

35072244

Keywords

pre-eclampsia
Human leukocyte antigen-G
hsa_circ_0051326
serum

Authors

Li Wang
Xue Wang
Xiaoju Chen
Dongcai Wu
Hui Cen
Dongrui Mao
Yuqiao Mo
Linmei Zheng

References (34)
  1. Filipek A, Jurewicz E. [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2018; 64(4): 232–229.
  2. Waugh J, Hooper R, Lamb E, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis. Health Technol Assess. 2017; 21(61): 1–90.
  3. Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014; 5: 125.
  4. Chen CP, Aplin JD, Haigh T, et al. Tissue interactions in the control of trophoblast invasion. J Reprod Fertil Suppl. 2000; 55(2): 57–64.
  5. El-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol. 2017; 56(5): 593–598.
  6. Durmanova V, Drobny J, Shawkatova I, et al. Analysis of HLA-G gene polymorphisms in Slovak women with pre-eclampsia. Bratisl Lek Listy. 2017; 118(9): 517–522.
  7. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990; 248(4952): 220–223.
  8. Djurisic S, Teiblum S, Tolstrup CK, et al. Allelic imbalance modulates surface expression of the tolerance-inducing HLA-G molecule on primary trophoblast cells. Mol Hum Reprod. 2015; 21(3): 281–295.
  9. Agrawal S, Pandey MK. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus. J Hematother Stem Cell Res. 2003; 12(6): 749–756.
  10. Yie Sm, Li Lh, Li Ym, et al. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol. 2004; 191(2): 525–529.
  11. Paridaens H, Gruson D. Pre-eclampsia: overview on the role of biomarkers in 2016. Ann Biol Clin (Paris). 2017; 75(3): 245–258.
  12. Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: Identification, biogenesis and function. Biochim Biophys Acta. 2016; 1859(1): 163–168.
  13. Lasda E, Parker R. Circular RNAs Co-Precipitate with Extracellular Vesicles: A Possible Mechanism for circRNA Clearance. PLoS One. 2016; 11(2): e0148407.
  14. Zhang YG, Yang HL, Long Y, et al. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG. 2016; 123(13): 2113–2118.
  15. Qian Y, Lu Y, Rui C, et al. Potential significance of circular RNA in human placental tissue for patients with preeclampsia. Cell Physiol Biochem. 2016; 39(4): 1380–1390.
  16. Panda AC, Dudekula DB, Abdelmohsen K, et al. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016; 13(1): 34–42.
  17. Panda AC, Abdelmohsen K, Gorospe M. RT-qPCR detection of senescence-associated circular RNAs. Methods Mol Biol. 2017; 1534: 79–87.
  18. Panda AC, De S, Grammatikakis I, et al. High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs. Nucleic Acids Res. 2017; 45(12): e116.
  19. Ferreira LMR, Meissner TB, Tilburgs T, et al. HLA-G: At the interface of maternal-fetal tolerance. Trends Immunol. 2017; 38(4): 272–286.
  20. Zidi I, Rizzo R, Bouaziz A, et al. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion. Hum Immunol. 2016; 77(4): 342–345.
  21. Hsu P, Santner-Nanan B, Joung S, et al. Expansion of CD4(+) HLA-G(+) T Cell in human pregnancy is impaired in pre-eclampsia. Am J Reprod Immunol. 2014; 71(3): 217–228.
  22. Wang Y, Huang M, Yang X, et al. Supplementing punicalagin reduces oxidative stress markers and restores angiogenic balance in a rat model of pregnancy-induced hypertension. Korean J Physiol Pharmacol. 2018; 22(4): 409–417.
  23. Bidarimath M, Tayade C. Pregnancy and spontaneous fetal loss: A pig perspective. Mol Reprod Dev. 2017; 84(9): 856–869.
  24. Klitkou L, Dahl M, Hviid TV, et al. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term. Hum Immunol. 2015; 76(4): 254–259.
  25. Moffett A, Hiby SE. How does the maternal immune system contribute to the development of pre-eclampsia? Placenta. 2007; 28 Suppl A: S51–S56.
  26. Steinborn A, Varkonyi T, Scharf A, et al. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol. 2007; 57(4): 277–286.
  27. Yie Sm, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol. 2005; 193(1): 204–208.
  28. Nowak I, Wilczyńska K, Radwan P, et al. Association of soluble HLA-G plasma level and genetic polymorphism with pregnancy outcome of patients undergoing fertilization embryo transfer. Front Immunol. 2019; 10: 2982.
  29. Zhang Hd, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018; 25(1): 1–7.
  30. Liu L, Wang J, Khanabdali R, et al. Circular RNAs: Isolation, characterization and their potential role in diseases. RNA Biol. 2017; 14(12): 1715–1721.
  31. Jiang M, Lash GE, Zhao X, et al. CircRNA-0004904, CircRNA-0001855, and PAPP-A: Potential Novel Biomarkers for the Prediction of Preeclampsia. Cell Physiol Biochem. 2018; 46(6): 2576–2586.
  32. Shafabakhsh R, Mirhosseini N, Chaichian S, et al. Could circRNA be a new biomarker for pre-eclampsia? Mol Reprod Dev. 2019; 86(12): 1773–1780.
  33. Huiyan W, Guangtong S, Wenbai Z, et al. Expression profile of circular RNAs in placentas of women with gestational diabetes mellitus. Endocr J. 2019; 66(5): 431–441.
  34. Yan L, Feng J, Cheng F, et al. Circular RNA expression profiles in placental villi from women with gestational diabetes mellitus. Biochem Biophys Res Commun. 2018; 498(4): 743–750.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl